These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Diagnosis, phenotype, and prevalence of polycystic ovary syndrome. Carmina E; Azziz R Fertil Steril; 2006 Jul; 86 Suppl 1():S7-8. PubMed ID: 16798288 [TBL] [Abstract][Full Text] [Related]
7. Polycystic ovaries are common in women with hyperandrogenic chronic anovulation but do not predict metabolic or reproductive phenotype. Legro RS; Chiu P; Kunselman AR; Bentley CM; Dodson WC; Dunaif A J Clin Endocrinol Metab; 2005 May; 90(5):2571-9. PubMed ID: 15713728 [TBL] [Abstract][Full Text] [Related]
8. Environmental determinants of polycystic ovary syndrome. Merkin SS; Phy JL; Sites CK; Yang D Fertil Steril; 2016 Jul; 106(1):16-24. PubMed ID: 27240194 [TBL] [Abstract][Full Text] [Related]
9. Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome. Dumesic DA; Oberfield SE; Stener-Victorin E; Marshall JC; Laven JS; Legro RS Endocr Rev; 2015 Oct; 36(5):487-525. PubMed ID: 26426951 [TBL] [Abstract][Full Text] [Related]
10. Phenotypes and body mass in women with polycystic ovary syndrome identified in referral versus unselected populations: systematic review and meta-analysis. Lizneva D; Kirubakaran R; Mykhalchenko K; Suturina L; Chernukha G; Diamond MP; Azziz R Fertil Steril; 2016 Nov; 106(6):1510-1520.e2. PubMed ID: 27530062 [TBL] [Abstract][Full Text] [Related]
11. Diagnosis, epidemiology, and genetics of the polycystic ovary syndrome. Goodarzi MO; Azziz R Best Pract Res Clin Endocrinol Metab; 2006 Jun; 20(2):193-205. PubMed ID: 16772151 [TBL] [Abstract][Full Text] [Related]
13. A genetic risk score is associated with polycystic ovary syndrome-related traits. Lee H; Oh JY; Sung YA; Chung HW Hum Reprod; 2016 Jan; 31(1):209-15. PubMed ID: 26573528 [TBL] [Abstract][Full Text] [Related]
14. Characteristics of different phenotypes of polycystic ovary syndrome based on the Rotterdam criteria in the Croatian population. Baldani DP; Skrgatić L; Simunić V; Zlopasa G; Canić T; Trgovcić I Coll Antropol; 2013 Jun; 37(2):477-82. PubMed ID: 23940993 [TBL] [Abstract][Full Text] [Related]
15. The polycystic ovary syndrome evolutionary paradox: a genome-wide association studies-based, in silico, evolutionary explanation. Casarini L; Brigante G J Clin Endocrinol Metab; 2014 Nov; 99(11):E2412-20. PubMed ID: 25093623 [TBL] [Abstract][Full Text] [Related]
17. [Current diagnosis of polycystic ovary syndrome: expanding the phenotype but generating new questions]. Merino P; Schulin-Zeuthen C; Codner E Rev Med Chil; 2009 Aug; 137(8):1071-80. PubMed ID: 19915773 [TBL] [Abstract][Full Text] [Related]
18. The prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome in treatment-naïve transgender people assigned female at birth. Oğuz SH; Boyraz BS; Ertürk B; Yıldız BO Endocrine; 2024 Apr; 84(1):287-292. PubMed ID: 38141060 [TBL] [Abstract][Full Text] [Related]
19. The phenotypic diversity in per-follicle anti-Müllerian hormone production in polycystic ovary syndrome. Alebić MŠ; Stojanović N; Duhamel A; Dewailly D Hum Reprod; 2015 Aug; 30(8):1927-33. PubMed ID: 26048913 [TBL] [Abstract][Full Text] [Related]
20. Type 2 diabetes and the polycystic ovary syndrome. Pelusi B; Gambineri A; Pasquali R Minerva Ginecol; 2004 Feb; 56(1):41-51. PubMed ID: 14973409 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]